SANTÉ INVESTS AT THE LEADING EDGE OF INNOVATION IN HEALTHCARE AND TECHNOLOGY. WE MANAGE OVER A HALF-BILLION DOLLARS OF CAPITAL IN TWO SEPARATE STRATEGIES.
Privately Held Companies
Santé Ventures invests in innovative new healthcare companies, with a particular focus in Biotech, Medtech, and Healthtech.
Publicly Traded Securities
Santé Capital applies state-of-the-art data science and machine learning technologies to generate attractive risk-adjusted returns in a systematic liquid strategy.
02 Santé Ventures Strategy
We search the emerging technology landscape for visionary entrepreneurs and innovative new ideas with the potential to deliver better patient health outcomes through advances in biology, medicine, and information.
03 Santé Capital Strategy
We leverage the latest advances in big data, machine learning, and natural language processing to systematically capture investment opportunities in a liquid portfolio of mispriced publicly traded securities.
04 NewsroomSee All News
Eric Epstein Joins Santé Ventures
September 24, 2019
Santé Appoints Diane Brouillard Head of Talent and Networks
September 17, 2019
Iterion Therapeutics Initiates Enrollment of Phase 2a Dose Expansion Study of Tegavivint in Patients with Desmoid Tumors
July 28, 2020
Remedy CEO and founder, Jeremy Gabrysch, MD, featured on the Fast Break podcast by Fast Company
July 24, 2020